$HSTM
HEALTHSTREAM INC Stock $hstm

$hstm Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000143774923011371 Filed on April 27, 2023

Income Statement

Concept	2023 Q2	2023 Q1	2022 Q4
Revenue	$69.20M	$68.95M	$68.54M
YoY Change	5.42%	5.48%	6.52%
Cost Of Revenue	$23.57M	$23.86M	$23.54M
YoY Change	6.0%	8.45%	2.42%
Gross Profit	$45.63M	$45.09M	$45.00M
YoY Change	5.13%	3.97%	8.8%
Gross Profit Margin	65.94%	65.4%	65.66%
Selling, General & Admin	$17.57M	$17.89M	$20.50M
YoY Change	-2.11%	-8.71%	-2.33%
% of Gross Profit	38.5%	39.68%	45.57%
Research & Development	$11.03M	$11.68M	$11.81M
YoY Change	4.23%	12.18%	3.08%
% of Gross Profit	24.17%	25.9%	26.24%
Depreciation & Amortization	$10.22M	$9.926M	$9.611M
YoY Change	8.51%	6.48%	2.57%
% of Gross Profit	22.4%	22.01%	21.36%
Operating Expenses	$41.62M	$11.68M	$41.92M
YoY Change	293.3%	12.18%	0.25%
Operating Profit	$4.008M	$2.891M	$3.077M
YoY Change	35.73%	-28.35%	-768.91%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net	$492.0K	$250.0K	$191.0K
YoY Change	-27.54%	-190.58%	-589.74%
Pretax Income	$4.500M	$3.141M	$3.268M
YoY Change	23.9%	-16.44%	-754.91%
Income Tax	$367.0K	$500.0K	$819.0K
% Of Pretax Income	8.16%	15.92%	25.06%
Net Earnings	$4.133M	$2.623M	$2.449M
YoY Change	34.06%	-9.33%	-732.82%
Net Earnings / Revenue	5.97%	3.8%	3.57%
Basic Earnings Per Share	$0.13	$0.09
Diluted Earnings Per Share	$0.13	$0.09	$0.08
COMMON SHARES
Basic Shares Outstanding	30.68M	30.58M	30.57M
Diluted Shares Outstanding	30.78M	30.66M

Balance Sheet

Concept	2023 Q2	2023 Q1	2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$55.96M	$58.65M	$53.91M
YoY Change	42.7%	29.26%	3.78%
Cash & Equivalents	$25.81M	$48.84M	$46.02M
Short-Term Investments	$30.16M	$9.818M	$7.885M
Other Short-Term Assets	$21.17M	$8.207M	$8.688M
YoY Change	83.47%	-16.87%	-19.73%
Inventory
Prepaid Expenses
Receivables	$40.88M	$41.56M	$36.73M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$118.0M	$125.1M	$114.4M
YoY Change	23.79%	16.68%	7.05%
LONG-TERM ASSETS
Property, Plant & Equipment	$35.94M	$14.69M	$15.48M
YoY Change	118.11%	-13.95%	-13.74%
Goodwill	$191.3M	$191.1M	$192.4M
YoY Change	1.82%	4.55%	5.42%
Intangibles			$81.55M
YoY Change			-8.58%
Long-Term Investments	$4.277M	$4.391M	$4.518M
YoY Change	-28.65%	-35.11%	-35.85%
Other Assets	$29.59M	$662.0K	$808.0K
YoY Change	2969.09%	-29.42%	-20.47%
Total Long-Term Assets	$375.5M	$378.1M	$383.4M
YoY Change	-1.81%	0.36%	0.91%
TOTAL ASSETS
Total Short-Term Assets	$118.0M	$125.1M	$114.4M
Total Long-Term Assets	$375.5M	$378.1M	$383.4M
Total Assets	$493.5M	$503.2M	$497.7M
YoY Change	3.3%	3.97%	2.26%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$22.15M	$20.12M	$7.287M
YoY Change	20.67%	13.24%	42.16%
Accrued Expenses	$5.236M	$6.533M	$25.01M
YoY Change	11.52%	-5.51%	52.79%
Deferred Revenue	$81.77M	$94.35M	$79.47M
YoY Change	-0.12%	4.97%	7.66%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$109.2M	$121.0M	$117.2M
YoY Change	4.04%	5.62%	16.8%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$26.22M	$2.195M	$2.210M
YoY Change	1697.4%	49.83%	49.63%
Total Long-Term Liabilities	$26.22M	$2.195M	$2.210M
YoY Change	1697.4%	49.83%	49.63%
TOTAL LIABILITIES
Total Short-Term Liabilities	$109.2M	$121.0M	$117.2M
Total Long-Term Liabilities	$26.22M	$2.195M	$2.210M
Total Liabilities	$152.9M	$123.2M	$119.4M
YoY Change	43.7%	6.18%	17.28%
SHAREHOLDERS EQUITY
Retained Earnings	$85.44M	$82.07M	$80.21M
YoY Change	15.3%	15.57%	17.75%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$340.6M	$336.0M	$334.1M
YoY Change
Total Liabilities & Shareholders Equity	$493.5M	$503.2M	$497.7M
YoY Change	3.3%	3.97%	2.26%

Cashflow Statement

Concept	2023 Q2	2023 Q1	2022 Q4
OPERATING ACTIVITIES
Net Income	$4.133M	$2.623M	$2.449M
YoY Change	34.06%	-9.33%	-732.82%
Depreciation, Depletion And Amortization	$10.22M	$9.926M	$9.611M
YoY Change	8.51%	6.48%	2.57%
Cash From Operating Activities	$4.948M	$20.54M	$8.108M
YoY Change	-32.46%	-0.55%	36.29%
INVESTING ACTIVITIES
Capital Expenditures	$6.246M	$879.0K	$6.140M
YoY Change	-203.12%	38.21%	-199.56%
Acquisitions		$6.621M
YoY Change		29995.45%
Other Investing Activities	-$20.13M	-$8.471M	-$4.222M
YoY Change	408.28%	-384.36%	62.14%
Cash From Investing Activities	-$26.38M	-$16.92M	-$10.36M
YoY Change	163.32%	326.96%	18.14%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-1.540M	-$791.0K	-47.00K
YoY Change	-54.87%	-96.09%	-99.18%
NET CHANGE
Cash From Operating Activities	4.948M	$20.54M	8.108M
Cash From Investing Activities	-26.38M	-$16.92M	-10.36M
Cash From Financing Activities	-1.540M	-$791.0K	-47.00K
Net Change In Cash	-22.97M	$2.813M	-2.301M
YoY Change	276.33%	-179.58%	-73.06%
FREE CASH FLOW
Cash From Operating Activities	$4.948M	$20.54M	$8.108M
Capital Expenditures	$6.246M	$879.0K	$6.140M
Free Cash Flow	-$1.298M	$19.66M	$1.968M
YoY Change	-109.7%	-1.78%	-83.76%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	46023000	usd
CY2023Q1	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	9818000	usd
CY2022Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	7885000	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	41556000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	36730000	usd
CY2023Q1	us-gaap	Unbilled Receivables Current UnbilledReceivablesCurrent	5732000	usd
CY2022Q4	us-gaap	Unbilled Receivables Current UnbilledReceivablesCurrent	5980000	usd
CY2023Q1	us-gaap	Prepaid Royalties PrepaidRoyalties	10959000	usd
CY2022Q4	us-gaap	Prepaid Royalties PrepaidRoyalties	9071000	usd
CY2023Q1	us-gaap	Other Assets Current OtherAssetsCurrent	8207000	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	8688000	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	125108000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	114377000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	14689000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	15483000	usd
CY2023Q1	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	38460000	usd
CY2022Q4	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	37118000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	22136000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	22759000	usd
CY2023Q1	us-gaap	Goodwill Goodwill	191102000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	192398000	usd
CY2023Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	383000	usd
CY2022Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	383000	usd
CY2023Q1	hstm	Contract With Customer Asset Sales Commission Noncurrent ContractWithCustomerAssetSalesCommissionNoncurrent	27122000	usd
CY2022Q4	hstm	Contract With Customer Asset Sales Commission Noncurrent ContractWithCustomerAssetSalesCommissionNoncurrent	28344000	usd
CY2023Q1	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	4391000	usd
CY2022Q4	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	4518000	usd
CY2023Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	662000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	808000	usd
CY2023Q1	us-gaap	Assets Assets	503159000	usd
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	616000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	544000	usd
CY2023Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	21326000	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	20280000	usd
CY2023Q1	us-gaap	Capitalized Computer Software Accumulated Amortization CapitalizedComputerSoftwareAccumulatedAmortization	110182000	usd
CY2022Q4	us-gaap	Capitalized Computer Software Accumulated Amortization CapitalizedComputerSoftwareAccumulatedAmortization	105025000	usd
CY2023Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q1	us-gaap	Common Stock No Par Value CommonStockNoParValue	0
CY2022Q4	us-gaap	Common Stock No Par Value CommonStockNoParValue	0
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	75000
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	75000
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	30682
CY2023Q1	us-gaap	Common Stock Other Shares Outstanding CommonStockOtherSharesOutstanding	30682
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	30579
CY2022Q4	us-gaap	Common Stock Other Shares Outstanding CommonStockOtherSharesOutstanding	30579
CY2023Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.025
CY2023Q1	us-gaap	Revenue Remaining Performance Obligation Percentage RevenueRemainingPerformanceObligationPercentage	0.44	pure
	hstm	Sales Commissions Amortization Term SalesCommissionsAmortizationTerm	P3Y
CY2023Q1	us-gaap	Dividend Payable Date To Be Paid Day Month And Year DividendPayableDateToBePaidDayMonthAndYear	2023-04-28
CY2023Q1	us-gaap	Dividends Payable Date Of Record Day Month And Year DividendsPayableDateOfRecordDayMonthAndYear	2023-04-17
CY2023Q1	us-gaap	Other Than Temporary Impairment Loss Debt Securities Available For Sale OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale	0	usd
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity File Number EntityFileNumber	000-27701
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	TN
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	62-1443555
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	500 11th Avenue North, Suite 1000
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Nashville
CY2023Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	TN
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	37203
CY2023Q1	dei	City Area Code CityAreaCode	615
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	301-3100
CY2023Q1	dei	Security12b Title Security12bTitle	Common Stock (Par Value $0.00)
CY2023Q1	dei	Trading Symbol TradingSymbol	HSTM
CY2023Q1	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	false
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	30682518
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	48836000	usd
CY2022Q4	us-gaap	Assets Assets	497741000	usd
CY2023Q1	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	20122000	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	32301000	usd
CY2023Q1	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	6533000	usd
CY2022Q4	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	5443000	usd
CY2023Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	94349000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	79469000	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	121004000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	117213000	usd
CY2023Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	18787000	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	17996000	usd
CY2023Q1	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	2562000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	2937000	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	22572000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	23321000	usd
CY2023Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	2195000	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	2210000	usd
CY2023Q1	us-gaap	Common Stocks Including Additional Paid In Capital CommonStocksIncludingAdditionalPaidInCapital	254986000	usd
CY2022Q4	us-gaap	Common Stocks Including Additional Paid In Capital CommonStocksIncludingAdditionalPaidInCapital	254832000	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	82069000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	80213000	usd
CY2023Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1016000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-981000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	336039000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	334064000	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	503159000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	497741000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	68946000	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	65367000	usd
CY2023Q1	us-gaap	Cost Of Goods And Service Excluding Depreciation Depletion And Amortization CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization	23856000	usd
CY2022Q1	us-gaap	Cost Of Goods And Service Excluding Depreciation Depletion And Amortization CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization	21998000	usd
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	11680000	usd
CY2022Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	10412000	usd
CY2023Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	11728000	usd
CY2022Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	10417000	usd
CY2023Q1	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	8865000	usd
CY2022Q1	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	9183000	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	9926000	usd
CY2022Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	9322000	usd
CY2023Q1	us-gaap	Costs And Expenses CostsAndExpenses	66055000	usd
CY2022Q1	us-gaap	Costs And Expenses CostsAndExpenses	61332000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	2891000	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	4035000	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	250000	usd
CY2022Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-276000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	3141000	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	3759000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	518000	usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	866000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	2623000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	2893000	usd
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.09
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.09
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.09
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.09
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	30591000
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	30955000
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	30659000
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	30976000
CY2023Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.025
CY2022Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	2623000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	2893000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-33000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	278000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-2000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-6000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-35000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	272000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	2588000	usd
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	3165000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	334064000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	2623000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-35000	usd
CY2023Q1	us-gaap	Dividends Common Stock DividendsCommonStock	767000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	945000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	-791000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	336039000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	339019000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	2893000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	272000	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	774000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	-497000	usd
CY2022Q1	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	19889000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	322572000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	2623000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	2893000	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	9926000	usd
CY2022Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	9322000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	945000	usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	774000	usd
CY2023Q1	us-gaap	Amortization Of Deferred Sales Commissions AmortizationOfDeferredSalesCommissions	2712000	usd
CY2022Q1	us-gaap	Amortization Of Deferred Sales Commissions AmortizationOfDeferredSalesCommissions	2484000	usd
CY2023Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	209000	usd
CY2022Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	6000	usd
CY2023Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	800000	usd
CY2022Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	684000	usd
CY2023Q1	hstm	Gain Loss On Non Marketable Equity Investments GainLossOnNonMarketableEquityInvestments	-127000	usd
CY2022Q1	hstm	Gain Loss On Non Marketable Equity Investments GainLossOnNonMarketableEquityInvestments	-276000	usd
CY2023Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	85000	usd
CY2022Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-26000	usd
CY2023Q1	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	4787000	usd
CY2022Q1	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	5874000	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Royalties IncreaseDecreaseInPrepaidRoyalties	1889000	usd
CY2022Q1	us-gaap	Increase Decrease In Prepaid Royalties IncreaseDecreaseInPrepaidRoyalties	2033000	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-482000	usd
CY2022Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-952000	usd
CY2023Q1	hstm	Increase Decrease In Deferred Commissions IncreaseDecreaseInDeferredCommissions	1490000	usd
CY2022Q1	hstm	Increase Decrease In Deferred Commissions IncreaseDecreaseInDeferredCommissions	2614000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-147000	usd
CY2022Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-79000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-4773000	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-3653000	usd
CY2023Q1	us-gaap	Increase Decrease In Royalties Payable IncreaseDecreaseInRoyaltiesPayable	1090000	usd
CY2022Q1	us-gaap	Increase Decrease In Royalties Payable IncreaseDecreaseInRoyaltiesPayable	1877000	usd
CY2023Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	14504000	usd
CY2022Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	15456000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	20541000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	20655000	usd
CY2023Q1	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	6621000	usd
CY2022Q1	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	22000	usd
CY2023Q1	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	1000000	usd
CY2022Q1	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	5025000	usd
CY2023Q1	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	2850000	usd
CY2022Q1	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	2024000	usd
CY2023Q1	us-gaap	Payments For Software PaymentsForSoftware	7566000	usd
CY2022Q1	us-gaap	Payments For Software PaymentsForSoftware	6305000	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	879000	usd
CY2022Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	636000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-16916000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-3962000	usd
CY2023Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	791000	usd
CY2022Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	497000	usd
CY2023Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	-0	usd
CY2022Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	19726000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-791000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-20223000	usd
CY2023Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-21000	usd
CY2022Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-5000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	2813000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-3535000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	46023000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	46905000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	48836000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	43370000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	68946000	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	65367000	usd
CY2023Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	200000	usd
CY2022Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	6000	usd
CY2023Q1	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	39100000	usd
CY2022Q1	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	34600000	usd
CY2023Q1	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	504000000	usd
CY2023Q1	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P12M
CY2023Q1	us-gaap	Amortization Of Deferred Sales Commissions AmortizationOfDeferredSalesCommissions	2700000	usd
CY2022Q1	us-gaap	Amortization Of Deferred Sales Commissions AmortizationOfDeferredSalesCommissions	2500000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	500000	usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	900000	usd
CY2023Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.16	pure
CY2022Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.23	pure
CY2023Q1	hstm	Income Tax Expense Benefit Discrete Adjustments IncomeTaxExpenseBenefitDiscreteAdjustments	-53000	usd
CY2023Q1	hstm	Effective Income Tax Rate Reconciliation Change In Estimated Tax Credits Amount EffectiveIncomeTaxRateReconciliationChangeInEstimatedTaxCreditsAmount	133000	usd
CY2023Q1	hstm	Effective Income Tax Rate Reconciliation Uncertain Tax Positions Amount EffectiveIncomeTaxRateReconciliationUncertainTaxPositionsAmount	80000	usd
CY2022Q1	hstm	Income Tax Expense Benefit Discrete Adjustments IncomeTaxExpenseBenefitDiscreteAdjustments	100000	usd
CY2023Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.025
CY2023Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	945000	usd
CY2022Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	774000	usd
CY2023Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	268000
CY2022Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	218000
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	2623000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	2893000	usd
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	30591000
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	30955000
CY2023Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	68000
CY2022Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	21000
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	30659000
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	30976000
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.09
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.09
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.09
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.09
CY2023Q1	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	9818000	usd
CY2023Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	2000	usd
CY2023Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	2000	usd
CY2023Q1	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	9818000	usd
CY2022Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	7882000	usd
CY2022Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	3000	usd
CY2022Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	-0	usd
CY2022Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	7885000	usd

Files In Submission

Name	View Source	Status
0001437749-23-011371-index-headers.html	Edgar Link	pending
0001437749-23-011371-index.html	Edgar Link	pending
0001437749-23-011371.txt	Edgar Link	pending
0001437749-23-011371-xbrl.zip	Edgar Link	pending
ex_472060.htm	Edgar Link	pending
ex_472061.htm	Edgar Link	pending
ex_472062.htm	Edgar Link	pending
ex_472063.htm	Edgar Link	pending
ex_502867.htm	Edgar Link	pending
ex_502868.htm	Edgar Link	pending
ex_502868img001.jpg	Edgar Link	pending
ex_502958.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
hstm-20230331.xsd	Edgar Link	pending
hstm20230331_10q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
hstm-20230331_def.xml	Edgar Link	unprocessable
hstm-20230331_lab.xml	Edgar Link	unprocessable
hstm-20230331_pre.xml	Edgar Link	unprocessable
hstm20230331_10q_htm.xml	Edgar Link	completed
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
sig01.jpg	Edgar Link	pending
hstm-20230331_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$HSTM
HEALTHSTREAM INC Stock $hstm

2023 Q2 Form 10-Q Financial Statement

#000143774923011371 Filed on April 27, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$HSTM HEALTHSTREAM INC Stock $hstm

2023 Q2 Form 10-Q Financial Statement

#000143774923011371 Filed on April 27, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$HSTM
HEALTHSTREAM INC Stock $hstm